Steven Girgenti - Aug 31, 2022 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Signature
/s/ Wilhelm E. Liebmann, as attorney-in-fact for Steven Girgenti
Stock symbol
BIAF
Transactions as of
Aug 31, 2022
Transactions value $
$510,336
Form type
4
Date filed
11/8/2022, 05:11 AM
Previous filing
Nov 8, 2022
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Conversion of derivative security $32.2K +7.66K $4.20 7.66K Sep 6, 2022 By Trust F1, F2, F3
transaction BIAF Common Stock Conversion of derivative security $658K +157K +62.82% $4.20 406K Sep 6, 2022 Direct F1, F4
transaction BIAF Common Stock Conversion of derivative security $32.2K +7.66K +1.89% $4.20 414K Sep 6, 2022 Direct F1, F5
transaction BIAF Common Stock Conversion of derivative security $248K +59.1K +14.3% $4.20 473K Sep 6, 2022 Direct F1, F6
transaction BIAF Common Stock Conversion of derivative security $247K +58.8K +12.44% $4.20 531K Sep 6, 2022 Direct F1, F7
transaction BIAF Common Stock Conversion of derivative security $115K +27.4K +5.15% $4.20 559K Sep 6, 2022 Direct F1, F8
transaction BIAF Common Stock Conversion of derivative security $20.6K +4.91K +0.88% $4.20 564K Sep 6, 2022 Direct F1, F9
transaction BIAF Common Stock Conversion of derivative security $11.3K +2.69K +0.48% $4.20 566K Sep 6, 2022 Direct F1, F10
transaction BIAF Common Stock Conversion of derivative security $56K +13.3K +2.35% $4.20 580K Sep 6, 2022 Direct F1, F11
transaction BIAF Common Stock Conversion of derivative security $44.7K +10.6K +1.83% $4.20 590K Sep 6, 2022 Direct F1, F12
transaction BIAF Common Stock Conversion of derivative security $165K +39.3K +6.65% $4.20 630K Sep 6, 2022 Direct F1, F13
transaction BIAF Common Stock Conversion of derivative security $65.7K +15.6K +2.48% $4.20 645K Sep 6, 2022 Direct F1, F14
transaction BIAF Common Stock Conversion of derivative security $151K +35.9K +5.56% $4.20 681K Sep 6, 2022 Direct F1, F15
transaction BIAF Common Stock Conversion of derivative security $500K +139K +20.4% $3.60 820K Sep 6, 2022 Direct F1, F16
transaction BIAF Common Stock Conversion of derivative security $9.99K +1.3K +16.95% $7.70 8.96K Sep 6, 2022 By Trust F1, F2, F17
transaction BIAF Common Stock Purchase +40.9K +4.99% 861K Aug 31, 2022 Direct F1, F18

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIAF Secured Convertible Promissory Note Conversion of derivative security -$32.2K 0 Sep 6, 2022 Common Stock 7.66K $4.20 By Trust F1, F2, F3
transaction BIAF Secured Convertible Promissory Note Conversion of derivative security -$658K 0 Sep 6, 2022 Common Stock 157K $4.20 Direct F1, F4
transaction BIAF Secured Convertible Promissory Note Conversion of derivative security -$32.2K 0 Sep 6, 2022 Common Stock 7.66K $4.20 Direct F1, F5
transaction BIAF Secured Convertible Promissory Note Conversion of derivative security -$248K 0 Sep 6, 2022 Common Stock 59.1K $4.20 Direct F1, F6
transaction BIAF Secured Convertible Promissory Note Conversion of derivative security -$247K 0 Sep 6, 2022 Common Stock 58.8K $4.20 Direct F1, F7
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$115K 0 Sep 6, 2022 Common Stock 27.4K $4.20 Direct F1, F8
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$20.6K 0 Sep 6, 2022 Common Stock 4.91K $4.20 Direct F1, F9
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$11.3K 0 Sep 6, 2022 Common Stock 2.69K $4.20 Direct F1, F10
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$56K 0 Sep 6, 2022 Common Stock 13.3K $4.20 Direct F1, F11
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$44.7K 0 Sep 6, 2022 Common Stock 10.6K $4.20 Direct F1, F12
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$165K 0 Sep 6, 2022 Common Stock 39.3K $4.20 Direct F1, F13
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$65.7K 0 Sep 6, 2022 Common Stock 15.6K $4.20 Direct F1, F14
transaction BIAF Unsecured Convertible Promissory Note Conversion of derivative security -$151K 0 Sep 6, 2022 Common Stock 35.9K $4.20 Direct F1, F15
transaction BIAF Series A Convertible Preferred Stock Conversion of derivative security $0 -973K -100% $0.00* 0 Sep 6, 2022 Common Stock 139K $3.60 Direct F1, F16
transaction BIAF Series A Convertible Preferred Stock Conversion of derivative security $0 -9.09K -100% $0.00* 0 Sep 6, 2022 Common Stock 1.3K $7.70 By Trust F1, F2, F17
transaction BIAF Warrants (right to buy) Purchase +40.9K 40.9K Aug 31, 2022 Common Stock 40.9K $7.35 Direct F1, F18
transaction BIAF Non-tradeable Warrants (right to buy) Purchase +40.9K 40.9K Aug 31, 2022 Common Stock 40.9K $7.66 Direct F1, F18
transaction BIAF Warrants (right to buy) Award +222K 222K Sep 6, 2022 Common Stock 222K $6.13 Direct F1, F19
transaction BIAF Warrants (right to buy) Purchase +5.95K 5.95K Sep 6, 2022 Common Stock 5.95K $6.13 By Trust F1, F2, F20
transaction BIAF Warrants (right to buy) Award +87.6K 87.6K Sep 6, 2022 Common Stock 87.6K $6.13 Direct F1, F21
transaction BIAF Warrants (right to buy) Award +35.7K 35.7K Sep 6, 2022 Common Stock 35.7K $6.13 Direct F1, F22
transaction BIAF Warrants (right to buy) Award +124K 124K Jul 20, 2022 Common Stock 124K $5.25 Direct F1, F23
transaction BIAF Warrants (right to buy) Purchase +2.38K 2.38K Jul 20, 2022 Common Stock 2.38K $5.25 By Trust F1, F2, F24
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the "Common Stock"), of bioAffinity Technologies, Inc. (the "Issuer"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the "IPO").
F2 These securities are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"), and indirectly by Mr. Girgenti as co-trustee of the Trust. Mr. Girgenti disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 In connection with the IPO Closing on September 6, 2022, the $32,161.64 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a "Note"), dated February 7, 2019, automatically converted into 7,657 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F4 In connection with the IPO Closing on September 6, 2022, the $657,731.96 of outstanding principal and accrued but unpaid interest of this secured Note, dated December 21, 2018, automatically converted into 156,602 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F5 In connection with the IPO Closing on September 6, 2022, the $32,161.64 of outstanding principal and accrued but unpaid interest of this secured Note, dated February 7, 2019, automatically converted into 7,657 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F6 In connection with the IPO Closing on September 6, 2022, the $248,394.52 of outstanding principal and accrued but unpaid interest of this secured Note, dated August 29, 2019, automatically converted into 59,141 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F7 In connection with the IPO Closing on September 6, 2022, the $246,947.95 of outstanding principal and accrued but unpaid interest of this secured Note, dated October 1, 2019, automatically converted into 58,797 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F8 In connection with the IPO Closing on September 6, 2022, the $114,991.78 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 22, 2020, automatically converted into 27,378 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F9 In connection with the IPO Closing on September 6, 2022, the $20,633.60 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 26, 2020, automatically converted into 4,912 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F10 In connection with the IPO Closing on September 6, 2022, the $11,317.26 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated January 13, 2021, automatically converted into 2,694 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F11 In connection with the IPO Closing on September 6, 2022, the $55,972.60 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated March 10, 2021, automatically converted into 13,326 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F12 In connection with the IPO Closing on September 6, 2022, the $44,655.34 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated March 24, 2021, automatically converted into 10,632 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F13 In connection with the IPO Closing on September 6, 2022, the $164,958.90 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated June 8, 2021, automatically converted into 39,275 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F14 In connection with the IPO Closing on September 6, 2022, the $65,654.79 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated July 3, 2021, automatically converted into 15,632 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F15 In connection with the IPO Closing on September 6, 2022, the $150,641.10 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated August 11, 2022, automatically converted into 35,866 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).
F16 In connection with the IPO Closing on September 6, 2022, the 972,957 shares of Series A Preferred Stock owned by Mr. Girgenti automatically converted at the then-effective 1-for-7 conversion rate into 138,993 fully paid and nonassessable shares of Common Stock. The Series A Preferred Stock had no expiration date.
F17 In connection with the IPO Closing on September 6, 2022, the 9,091 shares of Series A Preferred Stock owned by the Trust automatically converted at the then-effective 1-for-7 conversion rate into 1,298 fully paid and nonassessable shares of Common Stock. The Series A Preferred Stock had no expiration date.
F18 The reported securities are included within 40,916 Units purchased by Mr. Girgenti for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.
F19 Represents a right to purchase an aggregate of 221,933 shares of Common Stock underlying four warrants that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrants were issued to Mr. Girgenti on August 25, 2021 as consideration for his agreement to enter into an amendment to that certain Secured Convertible Note Purchase Agreement, dated December 21, 2018, as amended (the "Note Purchase Agreement") to extend the maturity date of the Notes issued to him under the Note Purchase Agreement from December 31, 2021 to May 31, 2022.
F20 Represents a right to purchase 5,952 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to the Trust on August 25, 2021 as consideration for the Trust's agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Note issued to the Trust under the Note Purchase Agreement from December 31, 2021 to May 31, 2022.
F21 Represents a right to purchase an aggregate of 87,605 shares of Common Stock underlying six warrants that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrants were issued to Mr. Girgenti on December 2, 2021 as consideration for his agreement to enter into amendments to extend the maturity dates of certain of his unsecured Notes to May 31, 2022.
F22 Represents a right to purchase 35,714 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Girgenti on August 11, 2022 as consideration for funds Mr. Girgenti paid to the Issuer for his unsecured Note, dated August 11, 2022.
F23 Represents a right to purchase 123,811 shares of Common Stock underlying 10 warrants at an exercise price of $5.25 per share. The warrants were issued to Mr. Girgenti on July 20, 2022 as consideration for his agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Notes issued to him under the Note Purchase Agreement from August 31, 2022 to October 31, 2022.
F24 Represents a right to purchase 2,380 shares of Common Stock underlying a warrant at an exercise price of $5.25 per share. The warrant was issued to the Trust on July 20, 2022 as consideration for the Trust's agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Note issued to the Trust under the Note Purchase Agreement from August 31, 2022 to October 31, 2022..

Remarks:

Exhibit 24.1: Power of Attorney (Steven Girgenti)